Masimo Corp. is sponsoring a new clinical study titled “Philips FAST SpO2 Technology With Masimo Sensors for SpO2 Monitoring in the Neonatal, Infant, and Pediatric Populations.” The goal is to confirm ...
Danaher Corp. is snapping up patient monitoring medtech Masimo in a $9.9 billion deal aimed at strengthening its diagnostics ...
News-Medical.Net on MSN
Danaher to acquire Masimo Corporation
Danaher Corporation, a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo Corporation a leading specialty diagnostics provider ...
More than a decade into their partnership, Masimo and GE HealthCare are still finding new ways to combine their respective patient monitoring technologies. In the latest expansion of their ...
Continuous Patient Monitoring with Masimo SET® Pulse Oximetry and Patient SafetyNet™ Universal Surveillance Monitoring with Masimo SET ® Pulse Oximetry and Patient SafetyNet™ – Repeatedly Shown to ...
Danaher Corporation (NYSE:DHR) announced it has entered into a definitive agreement to acquire Masimo Corporation (NASDAQ: ...
Rugged Handheld Device Provides Clinically Proven Masimo SET® Pulse Oximetry and Respiration Rate Monitoring IRVINE, Calif.--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today FDA clearance of ...
Noting that OSA “can only be reliably diagnosed using multichannel sleep studies, which are expensive, demanding for families and only available in specialist centres,” Dr. Hill and colleagues at the ...
New Neonatal Study Adds to Body of Clinical Evidence Demonstrating Masimo SET ® Pulse Oximetry’s Unique Ability to Improve Care NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) provides ...
Universal Surveillance Monitoring with Masimo SET ® Pulse Oximetry and Patient SafetyNet™ – Repeatedly Shown to Improve Patient Outcomes and Save Lives – Also Projected to Yield Significant Cost ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results